Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Enliven Therapeutics, Inc.
IPO Date: February 24, 2023
Sector: Healthcare
Industry: Biotech
Market Cap: $1.36B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.60 | 3.20%
Avg Daily Range (30 D): $0.81 | 4.13%
Avg Daily Range (90 D): $0.68 | 3.53%
Institutional Daily Volume
Avg Daily Volume: .18M
Avg Daily Volume (30 D): .45M
Avg Daily Volume (90 D): .29M
Trade Size
Avg Trade Size (Sh.): 67
Avg Trade Size (Sh.) (30 D): 71
Avg Trade Size (Sh.) (90 D): 61
Institutional Trades
Total Inst.Trades: 490
Avg Inst. Trade: $1.52M
Avg Inst. Trade (30 D): $1.08M
Avg Inst. Trade (90 D): $.95M
Avg Inst. Trade Volume: .07M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.5M
Avg Closing Trade (30 D): $1.21M
Avg Closing Trade (90 D): $.94M
Avg Closing Volume: 70.01K
   
News
Oct 14, 2024 @ 7:05 PM
Enliven Therapeutics, Inc. Is a Great Choice for '...
Source: Zacks
Sep 28, 2024 @ 1:35 PM
Enliven Therapeutics Announces Positive Data Updat...
Source: N/A
Jul 16, 2024 @ 10:44 PM
Enliven Therapeutics COO sells over $1.25m in comp...
Source: Investing.Com
May 29, 2024 @ 8:05 PM
Enliven Therapeutics to Present at Two Upcoming In...
Source: Enliven Therapeutics, Inc.
May 14, 2024 @ 8:05 PM
Enliven Therapeutics Reports First Quarter Financi...
Source: Enliven Therapeutics, Inc.
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.57 $-.46 $-1.89
Diluted EPS $-.57 $-.46 $-1.89
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -28.54M $ -23.18M $ -89.02M
Operating Income / Loss $ -31.69M $ -26.9M $ -104.55M
Cost of Revenue $ $ $
Net Cash Flow $ -22.47M $ 23.5M $ 23.98M
PE Ratio